{"id":"W4213176775","doi":"10.1016/j.jbo.2022.100416","title":"Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval","year":2022,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Amgen; National Multiple Sclerosis Society Michigan Chapter","keywords":"Denosumab; Medicine; Discontinuation; Multiple myeloma; Zoledronic acid; Dosing; Oncology; Osteonecrosis of the jaw; Bisphosphonate; Pathologic fracture; Internal medicine; Surgery; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008486246,0.0001887133,0.001714868,0.0003090439,0.00003130027,0.000002137152,0.0001698672,0.000233428,0.0002987169],"category_scores_gemma":[0.0001419076,0.0001098036,0.0004720653,0.0003030264,0.00006532339,0.00005225937,0.00003854352,0.0005995613,0.000004669734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004728854,"about_ca_system_score_gemma":0.00136165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001362589,"about_ca_topic_score_gemma":0.00002233512,"domain_scores_codex":[0.9975581,0.0003949205,0.001270131,0.0001682153,0.0003684344,0.0002402213],"domain_scores_gemma":[0.9976501,0.0002825433,0.00164035,0.0002620508,0.00007694121,0.00008796184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001718665,0.001662891,0.0003504222,0.004100972,0.0004161192,0.0009198172,0.0009323433,5.901302e-7,3.705079e-7,0.00001122568,0.0002805483,0.989606],"study_design_scores_gemma":[0.005300107,0.00884175,0.003004446,0.003526817,0.001727746,0.005788083,0.0002065415,0.000001107674,2.505957e-7,0.0000858144,0.9714184,0.00009887883],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02366458,0.9737795,0.00001086954,0.0001680648,0.0002891942,0.001834457,0.000009562138,0.000003106627,0.0002406662],"genre_scores_gemma":[0.007640609,0.989345,0.001142077,0.00008585997,0.00007565781,0.0005752814,0.00003907287,0.00003936702,0.00105708],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9895071,"threshold_uncertainty_score":0.4477659,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06026342711057341,"score_gpt":0.4142754096047931,"score_spread":0.3540119824942197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}